Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Health Canada states 6 months to 2 years for Din

<< Previous

Bullboard Posts

Next >>

Comment by SamV21on Oct 20, 2021 4:25pm

68 Views

Post# 34029130

RE:RE:RE:RE:RE:RE:RE:Health Canada states 6 months to 2 years for Din

I didn't say 4 or 5 similar applications .Golddetctor/liedetector did.This is an application depends on third party data typically 6 to 8 months. I think currently there are maybe 4 of 5 similar applications pending. See health Canada site for similar application. It is already approved in other countries. Look also ma&d it shows tbp getting comments to change font sizes. Most ppl didn't even look at the info.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks